DE69705316D1 - Phenoxyethylaminderivate, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und deren pharmazeutische zusammensetzungen - Google Patents
Phenoxyethylaminderivate, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und deren pharmazeutische zusammensetzungenInfo
- Publication number
- DE69705316D1 DE69705316D1 DE69705316T DE69705316T DE69705316D1 DE 69705316 D1 DE69705316 D1 DE 69705316D1 DE 69705316 T DE69705316 T DE 69705316T DE 69705316 T DE69705316 T DE 69705316T DE 69705316 D1 DE69705316 D1 DE 69705316D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- pharmaceutical compositions
- medicinal products
- phenoxyethylamine derivatives
- phenoxyethylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9611797A FR2753967B1 (fr) | 1996-09-27 | 1996-09-27 | Nouveaux derives de la phenoxyethylamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
PCT/FR1997/001690 WO1998013337A1 (fr) | 1996-09-27 | 1997-09-26 | Nouveaux derives de la phenoxyethylamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69705316D1 true DE69705316D1 (de) | 2001-07-26 |
DE69705316T2 DE69705316T2 (de) | 2002-02-28 |
Family
ID=9496125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69705316T Expired - Lifetime DE69705316T2 (de) | 1996-09-27 | 1997-09-26 | Phenoxyethylaminderivate, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und deren pharmazeutische zusammensetzungen |
Country Status (21)
Country | Link |
---|---|
US (2) | US5998666A (de) |
EP (1) | EP0929515B1 (de) |
JP (1) | JP2001503392A (de) |
AR (1) | AR008487A1 (de) |
AT (1) | ATE202335T1 (de) |
AU (1) | AU720483B2 (de) |
BR (1) | BR9711424A (de) |
CA (1) | CA2267251C (de) |
DE (1) | DE69705316T2 (de) |
DK (1) | DK0929515T3 (de) |
ES (1) | ES2160366T3 (de) |
FR (1) | FR2753967B1 (de) |
HU (1) | HUP9903928A3 (de) |
IL (1) | IL128918A (de) |
MY (1) | MY128191A (de) |
NO (1) | NO991482L (de) |
NZ (1) | NZ334622A (de) |
PL (1) | PL188747B1 (de) |
RU (1) | RU2181119C2 (de) |
TW (1) | TW415934B (de) |
WO (1) | WO1998013337A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050271186A1 (en) * | 2004-06-02 | 2005-12-08 | Audiopoint, Inc. | System, method and computer program product for interactive voice notification |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI832935A (fi) * | 1982-08-20 | 1984-02-21 | Midit | Derivat av w-aminosyror, deras framstaellning samt dessa derivat innehaollande blandningar |
US5677310A (en) * | 1993-08-19 | 1997-10-14 | Janssen Pharmaceutica N.V. | Vasoconstrictive substituted aryloxyalkyl diamines |
US5585492A (en) * | 1994-10-11 | 1996-12-17 | G. D. Searle & Co. | LTA4 Hydrolase inhibitors |
-
1996
- 1996-09-27 FR FR9611797A patent/FR2753967B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-24 AR ARP970104386A patent/AR008487A1/es active IP Right Grant
- 1997-09-26 ES ES97942999T patent/ES2160366T3/es not_active Expired - Lifetime
- 1997-09-26 AU AU44636/97A patent/AU720483B2/en not_active Ceased
- 1997-09-26 RU RU99108431/04A patent/RU2181119C2/ru not_active IP Right Cessation
- 1997-09-26 WO PCT/FR1997/001690 patent/WO1998013337A1/fr active IP Right Grant
- 1997-09-26 AT AT97942999T patent/ATE202335T1/de not_active IP Right Cessation
- 1997-09-26 JP JP51535098A patent/JP2001503392A/ja not_active Withdrawn
- 1997-09-26 HU HU9903928A patent/HUP9903928A3/hu unknown
- 1997-09-26 US US09/254,789 patent/US5998666A/en not_active Expired - Fee Related
- 1997-09-26 PL PL97332479A patent/PL188747B1/pl not_active IP Right Cessation
- 1997-09-26 IL IL12891897A patent/IL128918A/en not_active IP Right Cessation
- 1997-09-26 DK DK97942999T patent/DK0929515T3/da active
- 1997-09-26 EP EP97942999A patent/EP0929515B1/de not_active Expired - Lifetime
- 1997-09-26 BR BR9711424A patent/BR9711424A/pt not_active Application Discontinuation
- 1997-09-26 TW TW086114115A patent/TW415934B/zh not_active IP Right Cessation
- 1997-09-26 CA CA002267251A patent/CA2267251C/fr not_active Expired - Fee Related
- 1997-09-26 NZ NZ334622A patent/NZ334622A/xx unknown
- 1997-09-26 DE DE69705316T patent/DE69705316T2/de not_active Expired - Lifetime
- 1997-09-27 MY MYPI97004526A patent/MY128191A/en unknown
-
1999
- 1999-03-26 NO NO991482A patent/NO991482L/no unknown
- 1999-11-16 US US09/441,354 patent/US6150417A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5998666A (en) | 1999-12-07 |
CA2267251A1 (fr) | 1998-04-02 |
HUP9903928A3 (en) | 2000-08-28 |
JP2001503392A (ja) | 2001-03-13 |
DE69705316T2 (de) | 2002-02-28 |
FR2753967A1 (fr) | 1998-04-03 |
MY128191A (en) | 2007-01-31 |
AU720483B2 (en) | 2000-06-01 |
NO991482D0 (no) | 1999-03-26 |
DK0929515T3 (da) | 2001-10-15 |
FR2753967B1 (fr) | 1998-11-27 |
EP0929515B1 (de) | 2001-06-20 |
IL128918A (en) | 2002-09-12 |
ES2160366T3 (es) | 2001-11-01 |
IL128918A0 (en) | 2000-02-17 |
WO1998013337A1 (fr) | 1998-04-02 |
TW415934B (en) | 2000-12-21 |
ATE202335T1 (de) | 2001-07-15 |
BR9711424A (pt) | 1999-08-24 |
AR008487A1 (es) | 2000-01-19 |
EP0929515A1 (de) | 1999-07-21 |
PL188747B1 (pl) | 2005-04-29 |
AU4463697A (en) | 1998-04-17 |
HUP9903928A2 (hu) | 2000-03-28 |
PL332479A1 (en) | 1999-09-13 |
US6150417A (en) | 2000-11-21 |
CA2267251C (fr) | 2006-03-21 |
NO991482L (no) | 1999-03-26 |
NZ334622A (en) | 1999-11-29 |
RU2181119C2 (ru) | 2002-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE215951T1 (de) | Tetracyclische campothecineanalogue, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen | |
ATE245171T1 (de) | Methyliden-malonat nanopartikel, verfahren zu deren herstellung, und diese enthaltende pharmazeutische praeparate | |
ATE302754T1 (de) | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE69724142D1 (de) | Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel | |
ATE187167T1 (de) | Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
ATE279392T1 (de) | Indol-verbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre medizinische anwendung | |
ATE222236T1 (de) | Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE232879T1 (de) | Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
DE69715866D1 (de) | Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende, pharmazeutische zusammensetzungen | |
EE9900112A (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
DE69934781D1 (de) | Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen | |
ATE294175T1 (de) | 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
DE60033519D1 (de) | Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen | |
DE59610963D1 (de) | Neue phenylamidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE264837T1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
ATE304534T1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60022890D1 (de) | Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE211745T1 (de) | 10,13,15-trioxatricyclo(9.2.1.1. 9.6)- pentadecanon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
EP0978517A3 (de) | Triazolpurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE194616T1 (de) | Substituierte 4-phenyl-thiazole derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen die sie enthalten | |
ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE69520870D1 (de) | Esculetin Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellung | |
ATE244246T1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ATE289595T1 (de) | Neue pyrimidin-2,4,6-trion-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR |